MIAMI, Sept 13 – Celera Genomics (NYSE:CRA) of Rockville, Md., said Wednesday that it had launched its Single-Nucleotide Polymorphism Reference Database for the human genome.

Celera’s first database release contains 2.8 million SNPs, including 2.4 million unique, proprietary SNPs taken from Celera’s human genome sequencing work, which decoded the genomes of five donors. The other 400,000 SNPs were culled from public databases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.